1000024184

The company has faced a mountain of lawsuits worldwide and has recently admitted in court that its COVID-19 vaccine can cause blood clots. However, what hasn’t been widely disclosed is AstraZeneca's most recent Phase III two-year post-vaccine safety clinical trial study results, which is quite alarming.Based on AstraZeneca's Phase III clinical trial data, the adverse event figures are deeply concerning and this may be what really prompted the company to request the withdrawal of its product.You can read AstraZeneca's latest Phase III clinical trial data at the link below.https://www.dropbox.com/scl/fi/x8p52owqc15ig7kj8u58r/EU-CTR-2020-005226-28-v1-Results.pdf?rlkey=xp24vhv7lqzy39kyv11j61k8w&st=jjgn9e26&dl=0#experimental #genetherapy #longtermsafetytrials #riskvsbenefit #firstdonoharm